These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11774713)

  • 1. [The role of cholesterol in the pathogenesis of Alzheimer's disease].
    Michikawa M
    Nihon Ronen Igakkai Zasshi; 2001 Nov; 38(6):751-3. PubMed ID: 11774713
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cholesterol metabolic disorders and Alzheimer's disease].
    Hao JW; Li L
    Sheng Li Ke Xue Jin Zhan; 2005 Jan; 36(1):64-6. PubMed ID: 15881350
    [No Abstract]   [Full Text] [Related]  

  • 3. [Alzheimer's disease and apolipoprotein E].
    Yamaguchi H
    No To Shinkei; 1996 Nov; 48(11):981-90. PubMed ID: 8951889
    [No Abstract]   [Full Text] [Related]  

  • 4. Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers.
    Anthony IC; Norrby KE; Dingwall T; Carnie FW; Millar T; Arango JC; Robertson R; Bell JE
    Brain; 2010 Dec; 133(Pt 12):3685-98. PubMed ID: 21126996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
    Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
    J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction to the special issue on Alzheimer's disease.
    Pangalos MN; Randall AD
    Neuropharmacology; 2010; 59(4-5):219-20. PubMed ID: 20728692
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recent study on Alzheimer's disease].
    Hirai S
    Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):367-71. PubMed ID: 8315330
    [No Abstract]   [Full Text] [Related]  

  • 8. Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer's disease?
    Michikawa M
    J Neurosci Res; 2003 Apr; 72(2):141-6. PubMed ID: 12671988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol in Alzheimer's disease and other amyloidogenic disorders.
    Harris JR; Milton NG
    Subcell Biochem; 2010; 51():47-75. PubMed ID: 20213540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
    Harrington CR; Louwagie J; Rossau R; Vanmechelen E; Perry RH; Perry EK; Xuereb JH; Roth M; Wischik CM
    Am J Pathol; 1994 Dec; 145(6):1472-84. PubMed ID: 7992850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease, cholesterol, and statins: the junctions of important metabolic pathways.
    Silva T; Teixeira J; Remião F; Borges F
    Angew Chem Int Ed Engl; 2013 Jan; 52(4):1110-21. PubMed ID: 23280829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenesis of Alzheimer's disease].
    Alegre M; Noé E; Luquin MR
    Rev Med Univ Navarra; 1997; 41(1):46-57. PubMed ID: 9527714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease.
    Andersson ME; Sjölander A; Andreasen N; Minthon L; Hansson O; Bogdanovic N; Jern C; Jood K; Wallin A; Blennow K; Zetterberg H
    Int J Mol Med; 2007 Aug; 20(2):233-9. PubMed ID: 17611642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease.
    Williams S; Chalmers K; Wilcock GK; Love S
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):414-21. PubMed ID: 16008825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOE and cholesterol homeostasis in Alzheimer's disease.
    Leduc V; Jasmin-Bélanger S; Poirier J
    Trends Mol Med; 2010 Oct; 16(10):469-77. PubMed ID: 20817608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment.
    Garg S; Timm T; Mandelkow EM; Mandelkow E; Wang Y
    Neurobiol Aging; 2011 Jan; 32(1):1-14. PubMed ID: 20961659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease: beta-Amyloid protein and tau.
    Morishima-Kawashima M; Ihara Y
    J Neurosci Res; 2002 Nov; 70(3):392-401. PubMed ID: 12391602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cholesterol in amyloid cascade: cholesterol-dependent modulation of tau phosphorylation and mitochondrial function.
    Michikawa M
    Acta Neurol Scand Suppl; 2006; 185():21-6. PubMed ID: 16866907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol and pathological processes in Alzheimer's disease.
    Yanagisawa K
    J Neurosci Res; 2002 Nov; 70(3):361-6. PubMed ID: 12391598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanism underlying the development of Alzheimer's disease: implications of apolipoprotein E and presenilin].
    Yanagisawa K
    Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):455-7. PubMed ID: 11523146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.